Rajesh Kumar
Stock Analyst at HSBC
(4.45)
# 1,159
Out of 5,005 analysts
165
Total ratings
62.7%
Success rate
14.5%
Average return
Main Sectors:
Stocks Rated by Rajesh Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: NOVN Novartis AG | Reiterated: Buy | CHF 110.00 → CHF 135.00 | CHF 116.46 | +15.92% | 6 | Sep 23, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $300 → $315 | $265.21 | +18.77% | 11 | Sep 10, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Hold | $60 → $65 | $62.25 | +4.42% | 9 | Sep 10, 2026 | |
| SWX: ROP Roche Holding AG | Reiterated: Hold | CHF 365.00 → CHF 380.00 | CHF 364.10 | +4.37% | 5 | Sep 10, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Reiterated: Buy | €40.00 → €65.00 | €49.55 | +31.18% | 9 | Sep 10, 2026 | |
| EPA: SAN Sanofi | Reiterated: Buy | €100.00 | €74.39 | +34.43% | 5 | Sep 10, 2026 | |
| LON: AZN AstraZeneca PLC | Reiterated: Hold | 13,750p → 13,920p | 12,672p | +9.85% | 4 | Sep 10, 2026 | |
| LON: GSK GSK plc | Reiterated: Hold | 1,860p → 2,000p | 1,906p | +4.93% | 5 | Sep 10, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Sell | $850 → $940 | $1,170.14 | -19.67% | 10 | Sep 10, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $150 → $172 | $150.91 | +13.98% | 7 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $112 → $136 | $141.28 | -3.74% | 3 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $28 → $30 | $27.93 | +7.41% | 8 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $800 → $920 | $803.90 | +14.44% | 2 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 590.00 → CHF 640.00 | CHF 562.80 | +13.72% | 4 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $103 | $87.10 | +18.25% | 1 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €390.00 → €230.00 | €206.40 | +11.43% | 2 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $70 → $54 | $39.40 | +37.06% | 4 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 | $55.66 | +2.41% | 3 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $445 | $137.96 | +222.31% | 1 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $42.51 | +169.67% | 1 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $20 | $39.52 | n/a | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $82 | $152.67 | n/a | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $270 | $270.09 | n/a | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $660 → $670 | $658.52 | n/a | 3 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $230 → $280 | $221.09 | n/a | 2 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $69 → $86 | $182.56 | n/a | 3 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $182 → $237 | $221.17 | n/a | 6 | Feb 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €170.00 | €133.15 | n/a | 3 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $124 → $111 | $100.87 | n/a | 2 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 260.00 | kr 448.20 | n/a | 1 | Sep 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | 200p | 215p | n/a | 1 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | €33.00 | €39.30 | n/a | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 7,900p → 6,565p | 6,430p | n/a | 4 | Dec 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | 3,050p → 2,880p | 2,674p | n/a | 3 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 3,300 → CHF 2,860 | CHF 95.42 | n/a | 5 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €32.00 → €31.00 | €27.80 | n/a | 5 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | €76.00 → €92.00 | €78.96 | n/a | 2 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | 6,440p → 5,700p | 5,870p | n/a | 2 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 685p | 898p | n/a | 1 | Jan 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €92.00 → €96.00 | €60.22 | n/a | 7 | Sep 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €137.00 → €195.00 | €95.18 | n/a | 4 | Sep 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 3,200p | 2,675p | n/a | 1 | Mar 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | 625p → 1,000p | 760p | n/a | 3 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $35.80 | n/a | 1 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | 1,370p | 7,625p | n/a | 1 | Apr 6, 2020 |
Novartis AG
Sep 23, 2026
Reiterated: Buy
Price Target: CHF 110.00 → CHF 135.00
Current: CHF 116.46
Upside: +15.92%
AbbVie
Sep 10, 2026
Reiterated: Buy
Price Target: $300 → $315
Current: $265.21
Upside: +18.77%
Bristol-Myers Squibb Company
Sep 10, 2026
Reiterated: Hold
Price Target: $60 → $65
Current: $62.25
Upside: +4.42%
Roche Holding AG
Sep 10, 2026
Reiterated: Hold
Price Target: CHF 365.00 → CHF 380.00
Current: CHF 364.10
Upside: +4.37%
Bayer Aktiengesellschaft
Sep 10, 2026
Reiterated: Buy
Price Target: €40.00 → €65.00
Current: €49.55
Upside: +31.18%
Sanofi
Sep 10, 2026
Reiterated: Buy
Price Target: €100.00
Current: €74.39
Upside: +34.43%
AstraZeneca PLC
Sep 10, 2026
Reiterated: Hold
Price Target: 13,750p → 13,920p
Current: 12,672p
Upside: +9.85%
GSK plc
Sep 10, 2026
Reiterated: Hold
Price Target: 1,860p → 2,000p
Current: 1,906p
Upside: +4.93%
Eli Lilly and Company
Sep 10, 2026
Reiterated: Sell
Price Target: $850 → $940
Current: $1,170.14
Upside: -19.67%
Merck & Co.
Sep 10, 2026
Reiterated: Buy
Price Target: $150 → $172
Current: $150.91
Upside: +13.98%
Sep 10, 2026
Upgraded: Hold
Price Target: $112 → $136
Current: $141.28
Upside: -3.74%
Sep 10, 2026
Reiterated: Hold
Price Target: $28 → $30
Current: $27.93
Upside: +7.41%
Sep 10, 2026
Reiterated: Buy
Price Target: $800 → $920
Current: $803.90
Upside: +14.44%
Jul 6, 2026
Reiterated: Buy
Price Target: CHF 590.00 → CHF 640.00
Current: CHF 562.80
Upside: +13.72%
Jul 6, 2026
Reiterated: Hold
Price Target: $103
Current: $87.10
Upside: +18.25%
Jun 3, 2026
Reiterated: Buy
Price Target: €390.00 → €230.00
Current: €206.40
Upside: +11.43%
Dec 10, 2025
Reiterated: Hold
Price Target: $70 → $54
Current: $39.40
Upside: +37.06%
Dec 10, 2025
Reiterated: Buy
Price Target: $57
Current: $55.66
Upside: +2.41%
Dec 2, 2025
Reiterated: Buy
Price Target: $445
Current: $137.96
Upside: +222.31%
Dec 2, 2025
Reiterated: Buy
Price Target: $115
Current: $42.51
Upside: +169.67%
Apr 28, 2025
Reiterated: Buy
Price Target: $13 → $20
Current: $39.52
Upside: n/a
Dec 4, 2024
Reiterated: Hold
Price Target: $82
Current: $152.67
Upside: n/a
Dec 4, 2024
Reiterated: Buy
Price Target: $270
Current: $270.09
Upside: n/a
Apr 30, 2024
Reiterated: Buy
Price Target: $660 → $670
Current: $658.52
Upside: n/a
Apr 16, 2024
Upgraded: Buy
Price Target: $230 → $280
Current: $221.09
Upside: n/a
Feb 26, 2024
Downgraded: Sell
Price Target: $69 → $86
Current: $182.56
Upside: n/a
Feb 14, 2024
Reiterated: Buy
Price Target: $182 → $237
Current: $221.17
Upside: n/a
Dec 18, 2023
Upgraded: Buy
Price Target: €170.00
Current: €133.15
Upside: n/a
Oct 16, 2023
Downgraded: Hold
Price Target: $124 → $111
Current: $100.87
Upside: n/a
Sep 1, 2023
Reiterated: Buy
Price Target: kr 260.00
Current: kr 448.20
Upside: n/a
Mar 22, 2023
Reiterated: Sell
Price Target: 200p
Current: 215p
Upside: n/a
Mar 7, 2023
Downgraded: Sell
Price Target: €33.00
Current: €39.30
Upside: n/a
Dec 9, 2022
Reiterated: Buy
Price Target: 7,900p → 6,565p
Current: 6,430p
Upside: n/a
Oct 20, 2022
Reiterated: Hold
Price Target: 3,050p → 2,880p
Current: 2,674p
Upside: n/a
Apr 8, 2022
Downgraded: Hold
Price Target: CHF 3,300 → CHF 2,860
Current: CHF 95.42
Upside: n/a
Apr 8, 2022
Reiterated: Buy
Price Target: €32.00 → €31.00
Current: €27.80
Upside: n/a
Apr 8, 2022
Upgraded: Hold
Price Target: €76.00 → €92.00
Current: €78.96
Upside: n/a
Apr 8, 2022
Downgraded: Hold
Price Target: 6,440p → 5,700p
Current: 5,870p
Upside: n/a
Jan 26, 2022
Reiterated: Buy
Price Target: 685p
Current: 898p
Upside: n/a
Sep 28, 2021
Reiterated: Buy
Price Target: €92.00 → €96.00
Current: €60.22
Upside: n/a
Sep 28, 2021
Reiterated: Buy
Price Target: €137.00 → €195.00
Current: €95.18
Upside: n/a
Mar 19, 2021
Reiterated: Buy
Price Target: 3,200p
Current: 2,675p
Upside: n/a
Jan 13, 2021
Upgraded: Buy
Price Target: 625p → 1,000p
Current: 760p
Upside: n/a
May 6, 2020
Upgraded: Buy
Price Target: n/a
Current: $35.80
Upside: n/a
Apr 6, 2020
Reiterated: Hold
Price Target: 1,370p
Current: 7,625p
Upside: n/a